INCRETIN & RECEPTOR RESEARCH

MOTS-C and Mitochondrial Metabolic Pathway Research

Velox Peptides Research Team·Published May 2026·6 min read
Peptide Length
16 amino acids
Origin
Mitochondrial 12S rRNA
Key Pathway
AMPK signalling
HPLC Purity
≥99% (batch-verified)
For in vitro research use only. This summary of the preclinical literature is provided for scientific reference, not medical advice. MOTS-C is not for human or veterinary consumption.

What is MOTS-C?

MOTS-c is a small peptide (a short chain of amino acids, the building blocks of proteins) made of 16 amino acids. What is special is where it comes from: it is built using instructions stored inside the mitochondria (the tiny "power plants" inside cells that make energy). In lab studies, scientists look at MOTS-c as a chemical that helps control how cells handle energy and fuel, mostly by switching on a sensor called AMPK (explained below). It is sold strictly as a research chemical for in vitro use (test-tube and lab work only) — never for people or animals.

Here is why MOTS-c is unusual. Nearly every peptide in the body is built from instructions kept in the cell’s main control centre, the nucleus. MOTS-c is different — its instructions live inside the mitochondria instead. It is part of a small, fairly new group called mitochondrial-derived peptides (MDPs). These act like tiny messengers, carrying news from the mitochondria to the rest of the cell, including back to the nucleus.

MOTS-c was first described by Lee, Cohen and their team in 2015. It was one of the first of these mitochondrial messengers shown to have a clear job in controlling energy and fuel. That is why researchers are so interested in it as a way to study how the cell’s power plants report on their energy status.

AMPK and metabolic signalling

MOTS-c research focuses on one main thing — switching on the AMPK energy sensor — plus an eye-catching way it sends signals from the mitochondria to the nucleus, and several energy-related results seen in animal studies.

AMPK activation via the folate cycle

The best-studied thing about MOTS-c is that it switches on AMPK. AMPK is the cell’s "low-fuel light" — a sensor that turns on when a cell is running low on energy and tells it to bring in more sugar and burn more fat. The way MOTS-c does this is clever and roundabout: it gets in the way of a chemical process called the folate cycle. This causes a helper molecule named AICAR to build up, and that build-up is what flips AMPK on. In these studies, skeletal muscle (the muscle you move with) seems to be the main place this happens.

Mitochondrial-to-nuclear signalling

When a cell is under stress (for example, running short on energy), MOTS-c has been seen to move out of the mitochondria and travel into the nucleus — the cell’s control centre. There it teams up with proteins that switch genes on or off, helping turn on the cell’s defence and antioxidant genes (which protect against damage). This makes MOTS-c a rare, clear example of a peptide that physically carries a message from the power plants to the control centre — a big reason it is studied.

Insulin sensitivity, exercise and ageing

In whole-animal rodent studies, MOTS-c was linked to keeping the body better at responding to insulin (the hormone that helps cells take in sugar), even with age or a high-fat diet, and to less weight gain from that diet. It has also been described as a peptide that responds to exercise and is linked to fitness and age-related decline. This makes it a useful research probe for studying energy control and ageing. These are research observations only, not therapeutic effects in people.

Key research findings

The studies below are good examples of the early MOTS-c research (done in cells and animals, not people). They are summarised here for science reference only.

Metabolic homeostasis & AMPK
Lee C et al. — “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell Metabolism, 2015

The founding MOTS-c study: reported that the peptide targets skeletal muscle, activates AMPK via folate-cycle interference, and prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity in mice.

PMID: 25738459

Mitochondrial-to-nuclear signalling
Kim KH et al. — “The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress.” Cell Metabolism, 2018

Demonstrated that under metabolic stress MOTS-c moves to the nucleus and regulates nuclear stress-response and antioxidant gene expression in an AMPK-dependent manner — establishing it as a mitochondrial-to-nuclear signalling peptide.

PMID: 29983246

Research context

MOTS-C is part of our incretin & receptor research group, next to other chemicals studied for how they handle the body’s energy and fuel. Researchers looking at cell energy may study it alongside NAD+ building blocks and peptides like Retatrutide to compare the different ways these chemicals control fuel use.

Velox Peptides supply information

Velox Peptides supplies MOTS-C as a lyophilised (freeze-dried) powder at ≥99% purity, checked by HPLC (a lab method that measures how pure a sample is). A batch certificate of analysis is available on request. To work out how to mix the powder back into a liquid (reconstitute it), see the reconstitution calculator. Supplied strictly as a research chemical for in vitro (lab-only) use.

References & further reading

  1. Lee C et al. “The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.” Cell Metabolism, 2015. PMID: 25738459
  2. Kim KH et al. “The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress.” Cell Metabolism, 2018. PMID: 29983246
  3. Reynolds JC et al. “MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.” Nature Communications, 2021.

Summaries are paraphrased from the peer-reviewed preclinical literature. For full source citations, email veloxpeps@gmail.com.

Frequently asked questions

What is MOTS-C?
MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded in the mitochondrial 12S rRNA region. It is studied as a metabolic signalling molecule and supplied by Velox Peptides for in vitro research use only.
What pathway is MOTS-C associated with?
In preclinical models MOTS-C is most associated with activation of AMPK, a central cellular energy sensor, and with mitochondrial-to-nuclear stress signalling.
What purity is Velox Peptides MOTS-C?
MOTS-C is HPLC-verified at a minimum of ≥99% purity, with batch documentation available on request.
How does MOTS-C activate AMPK?
In preclinical studies MOTS-c interferes with the folate cycle and de novo purine biosynthesis, causing the AMPK-activating intermediate AICAR to accumulate, which switches on AMPK — primarily in skeletal muscle.
Why is MOTS-C called a mitochondrial-derived peptide?
Unlike most peptides, MOTS-c is encoded within the mitochondrial genome (the 12S rRNA region) rather than the cell nucleus, which is why it is classed as a mitochondrial-derived peptide (MDP).
Is MOTS-C legal to buy in the UK?
Yes — for in vitro research purposes. It is not a licensed medicine and not approved for human use. Velox Peptides supplies it solely as a research reagent.
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.

All research summaries on this page are derived from publicly available peer-reviewed literature. Velox Peptides makes no therapeutic claims. For research use only.